EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Severe Asthma in School-Age Children: An Updated Appraisal on Biological Options and Challenges in This Age Group

Cristiana Indolfi, Angela Klain iD, Maria Cristina Capuano, Simone Colosimo iD, Renata Rapillo, Michele Miraglia Del Giudice iD

Children · 29.01.2025 · 12 (2) · 167

DOI: 10.3390/children12020167 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Children, online erschienen am 29.01.2025. Verfasst von Cristiana Indolfi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Woman, Child and General and Specialized Surgery, University of Campania 'Luigi Vanvitelli', 80138 Naples, Italy. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This review examines the growing role of biological therapies in managing severe asthma in children aged 6–11 years. Severe asthma, characterized by persistent symptoms and frequent exacerbations, presents significant challenges in pediatric care. Biologic treatments, including mepolizumab, omalizumab, and dupilumab, provide targeted interventions for patients with high eosinophilic inflammation or allergic asthma (T2-high asthma). Alongside their therapeutic benefits, the review evaluates the safety profiles of these biologics, highlighting potential side effects and the necessity for monitoring during long-term use. Cost considerations and treatment adherence also emerge as important challenges that need to be addressed in clinical practice. Additionally, the review emphasizes the need for identifying patients who would derive the most benefit from biologic therapies, advocating for the development of biomarkers to aid in treatment decisions. Emerging biologics, such as tezepelumab, are introduced as promising alternatives with the potential to target upstream inflammatory pathways, offering hope for treating T2-low asthma forms, which currently lack effective treatment options in children.

Schlagwörter

Stichwörter der Autor:innen

biologicalsbiomarkerschildrenschool-agesevere asthmatreatment

Autor:innen und Institutionen

  • Department of Woman, Child and General and Specialized Surgery, University of Campania 'Luigi Vanvitelli', 80138 Naples, Italy.

ORCID-Profile: Angela Klain, Simone Colosimo, Michele Miraglia Del Giudice

Zitieren

APA

Indolfi, C., Klain, A., Capuano, M. C., Colosimo, S., Rapillo, R., & Miraglia Del Giudice, M. (2025). Severe Asthma in School-Age Children: An Updated Appraisal on Biological Options and Challenges in This Age Group. Children, 12(2), 167. https://doi.org/10.3390/children12020167

Vancouver

Indolfi C, Klain A, Capuano MC, Colosimo S, Rapillo R, Miraglia Del Giudice M. Severe Asthma in School-Age Children: An Updated Appraisal on Biological Options and Challenges in This Age Group. Children. 2025;12(2):167. doi:10.3390/children12020167

BibTeX
@article{Indolfi2025,
  author = {Indolfi, Cristiana and Klain, Angela and Capuano, Maria Cristina and Colosimo, Simone and Rapillo, Renata and Miraglia Del Giudice, Michele},
  title = {Severe Asthma in School-Age Children: An Updated Appraisal on Biological Options and Challenges in This Age Group},
  journal = {Children},
  year = {2025},
  volume = {12},
  number = {2},
  pages = {167},
  doi = {10.3390/children12020167}
}
Kostenlos starten →